IL22 and type 1 diabetes mellitus: The objective of this study was to determine whether the CFA-induced cytokine, IL-22, was in part responsible for inducing Reg2 expression and other gene family members, Reg1 and Reg3δ, leading to a subsequent increase in β-cell mass and reversal of T1D development.